サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1536673

中枢神経系リンパ腫治療市場：タイプ別、用途別、エンドユーザー別、国別、地域別：産業分析、市場規模、市場シェア、2024年～2032年予測

Central Nervous System Lymphoma Treatment Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 301 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
中枢神経系リンパ腫治療市場：タイプ別、用途別、エンドユーザー別、国別、地域別：産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年08月04日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

中枢神経系リンパ腫治療市場規模は2023年に1,239億232万米ドルとなり、2024年から2032年にかけてCAGR 4.90％で拡大

中枢神経系リンパ腫治療市場-市場力学

中枢神経系リンパ腫の有病率の上昇と腫瘍学への投資の増加が市場の需要を促進する見込み

人口の高齢化と診断技術の向上もあり、中枢神経系リンパ腫の症例数が増加しており、効果的な治療に対する需要が高まっています。疾患に対する認識と画像診断の進歩は、発見率の向上に寄与します。薬剤開発の革新と、標的治療や免疫療法などの新しい治療のイントロダクションは、主要な推進力です。中枢神経系リンパ腫の分子メカニズムの理解を深める研究は、より効果的で個別化された治療法の開発につながります。したがって、研究開発も市場開拓を後押しすると期待されます。

製薬会社やバイオテクノロジー企業を含む非公開会社による腫瘍学研究への投資の増加は、中枢神経系リンパ腫の新しい治療法の開発を加速させています。MRI、PETスキャン、脳脊髄液分析などの診断技術の進歩により、中枢神経系リンパ腫の早期発見とモニタリングが改善され、それが高度な治療オプションの需要を後押ししています。中枢神経系リンパ腫に対する認識と擁護活動の高まりは、研究開発資金の増加に寄与しています。患者擁護団体や組織は認知度を高める役割を果たし、それが資金や治療選択肢に影響を与えることがあります。

中枢神経系リンパ腫治療市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約4.90%のCAGRで毎年成長すると推定されます。

タイプ別セグメンテーションに基づくと、化学療法セグメントは、がんの有病率の増加により、2023年に最大の市場シェアを示すと予測されました。

用途別セグメントでは、化学療法やその他の治療における治療ニーズが高いことから、2023年には治療薬セグメントが主要用途となった。

エンドユーザーセグメンテーションに基づくと、がん治療、神経系障害の手術などのニーズが高いことから、2023年のエンドユーザーは病院セグメントがトップでした。

地域別では、神経系関連疾患の有病率の高さから、北米が2023年の主要収益源でした。

中枢神経系リンパ腫治療市場-セグメンテーション分析：

中枢神経系リンパ腫治療の世界市場は、タイプ、用途、エンドユーザー、地域に基づいてセグメント化されます。

化学療法、放射線療法、ステロイド療法、標的療法、その他です。化学療法分野が市場を独占しています。化学療法は中枢神経系リンパ腫の主要治療法です。高用量のメトトレキサートは、血液脳関門を通過して中枢神経系内のがん細胞を標的にできるため、一般的に使用されています。

市場は用途別に治療薬、臨床試験、その他の3つに分類されます。治療薬セグメントは市場で最大のシェアを占めると予測されています。無動緘黙治療薬は中枢神経系治療において非常に好まれており、これがセグメントの成長を後押ししています。

市場はエンドユーザーによって、病院、クリニック、その他の3つに分類されます。病院分野は市場を独占しており、予測期間中も高い優位性を維持すると予想されます。MRI、PETスキャン、脳脊髄液分析などの診断技術の進歩により、病院の治療設備が向上しています。

中枢神経系リンパ腫治療市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。北米は、高い罹患率、高度なヘルスケアインフラ、充実した研究投資により、中枢神経系リンパ腫治療市場で大きなシェアを占めています。米国は、標的療法や免疫療法を含む臨床試験や新しい治療法の開発でリードしています。有望な治療法の早期承認など、FDAの承認プロセスが市場の成長を支えています。

中枢神経系リンパ腫治療市場-競合情勢：

中枢神経系リンパ腫治療市場の競争は中程度です。Roche、Bristol-Myers Squibb、Novartis、Eli Lilly、Celgeneなどの大手製薬企業やバイオテクノロジー企業が中枢神経系リンパ腫治療開発に積極的に取り組んでいます。各社は、モノクローナル抗体や新規の化学療法剤などの革新的な治療を含む、中枢神経系リンパ腫を標的としたいくつかの新しい治療法のFDA承認を取得しつつあります。主要企業には、バイエル、サノフィ、アストラゼネカ、GSKなどがあり、世界中で大きな存在感を示しています。

目次

第1章 中枢神経系リンパ腫治療市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 中枢神経系リンパ腫治療の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 中枢神経系リンパ腫治療産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 中枢神経系リンパ腫治療市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 中枢神経系リンパ腫治療市場情勢

  • 中枢神経系リンパ腫治療市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 中枢神経系リンパ腫治療市場- タイプ別

  • 概要
    • セグメントシェア分析（タイプ別）
    • 化学療法
    • 放射線治療
    • ステロイド療法
    • 標的療法
    • その他

第8章 中枢神経系リンパ腫治療市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 治療薬
    • 臨床試験
    • その他

第9章 中枢神経系リンパ腫治療市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • クリニック
    • その他
    • 薬局

第10章 中枢神経系リンパ腫治療市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 中枢神経系リンパ腫治療業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Roche
    • Bristol-Myers Squibb
    • Novartis AG
    • Eli Lilly
    • Celgene
    • Kite Pharma
    • Merck &Co.
    • AstraZeneca
    • Sanofi
    • AbbVie
    • Takeda Pharmaceuticals
    • Pfizer
    • Beigene
    • Eisai
    • Johnson &Johnson
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Central Nervous System Lymphoma Treatment Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Central Nervous System Lymphoma Treatment Market, by Type 2019-2032 (USD Million)
  • TABLE Central Nervous System Lymphoma Treatment Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Central Nervous System Lymphoma Treatment Market, by Application 2019-2032 (USD Million)
  • TABLE Central Nervous System Lymphoma Treatment Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Central Nervous System Lymphoma Treatment Market, by End User 2019-2032 (USD Million)
  • TABLE Central Nervous System Lymphoma Treatment Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Central Nervous System Lymphoma Treatment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Central Nervous System Lymphoma Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Central Nervous System Lymphoma Treatment Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Central Nervous System Lymphoma Treatment Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Central Nervous System Lymphoma Treatment Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Central Nervous System Lymphoma Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Central Nervous System Lymphoma Treatment Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Central Nervous System Lymphoma Treatment Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Central Nervous System Lymphoma Treatment Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Central Nervous System Lymphoma Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Central Nervous System Lymphoma Treatment Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Central Nervous System Lymphoma Treatment Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Central Nervous System Lymphoma Treatment Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Central Nervous System Lymphoma Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Central Nervous System Lymphoma Treatment Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Central Nervous System Lymphoma Treatment Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Central Nervous System Lymphoma Treatment Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Central Nervous System Lymphoma Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Central Nervous System Lymphoma Treatment Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Central Nervous System Lymphoma Treatment Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Central Nervous System Lymphoma Treatment Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Central Nervous System Lymphoma Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Central Nervous System Lymphoma Treatment Market share and leading players, 2023
  • FIGURE Europe Central Nervous System Lymphoma Treatment Market share and leading players, 2023
  • FIGURE Asia Pacific Central Nervous System Lymphoma Treatment Market share and leading players, 2023
  • FIGURE Latin America Central Nervous System Lymphoma Treatment Market share and leading players, 2023
  • FIGURE Middle East and Africa Central Nervous System Lymphoma Treatment Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Central Nervous System Lymphoma Treatment Market share analysis by country, 2023
  • FIGURE Germany Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Central Nervous System Lymphoma Treatment Market share analysis by country, 2023
  • FIGURE India Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Central Nervous System Lymphoma Treatment Market share analysis by country, 2023
  • FIGURE Brazil Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Central Nervous System Lymphoma Treatment Market share analysis by country, 2023
  • FIGURE Saudi Arabia Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Central Nervous System Lymphoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3522

REPORT HIGHLIGHT

Central Nervous System Lymphoma Treatment Market size was valued at USD 123,902.32 Million in 2023, expanding at a CAGR of 4.90% from 2024 to 2032.

Central Nervous System (CNS) lymphoma is a type of cancer that primarily affects the brain and spinal cord. Treating CNS lymphoma can be complex and often involves a combination of therapies. Managing symptoms and improving quality of life are important aspects of treatment. This might include medications to control symptoms like headaches, seizures, or swelling.

Central Nervous System Lymphoma Treatment Market- Market Dynamics

Rising prevalence of CNS lymphoma and increased investment in oncology are expected to propel market demand

An increase in the number of CNS lymphoma cases, partly due to an aging population and improved diagnostic techniques, drives demand for effective treatments. Awareness of the disease and advances in diagnostic imaging contribute to better detection rates. Innovations in drug development and the introduction of new therapies, such as targeted treatments and immunotherapies, are major drivers. Research into better understanding the molecular mechanisms of CNS lymphoma leads to the development of more effective and personalized treatment options. Thus, research developments are also expected to boost the market growth.

Higher investments in oncology research from both public and private sectors, including pharmaceutical companies and biotech firms, are accelerating the development of new CNS lymphoma treatments. Advances in diagnostic technologies, such as MRI, PET scans, and cerebrospinal fluid analysis, have improved early detection and monitoring of CNS lymphoma, which in turn drives the demand for advanced treatment options. Greater awareness and advocacy efforts for CNS lymphoma contribute to increased funding for research and development. Patient advocacy groups and organizations play a role in raising awareness, which can influence funding and treatment options.

Central Nervous System Lymphoma Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.90% over the forecast period (2024-2032)

Based on Type segmentation, the chemotherapy segment was predicted to show maximum market share in the year 2023, owing to the increased prevalence of cancer.

Based on Application segmentation, the therapeutics segment was the leading Application in 2023, due to the high need for therapies in chemotherapy and other treatments.

Based on End User segmentation, the hospital segment was the leading End User in 2023, owing to the high need for the treatment of cancer, surgery of nervous system disorders, etc.

On the basis of region, North America was the leading revenue generator in 2023, owing to the high prevalence of nervous system-related disorders.

Central Nervous System Lymphoma Treatment Market- Segmentation Analysis:

The Global Central Nervous System Lymphoma Treatment Market is segmented on the basis of Type, Application, End User, and Region.

The market is divided into five categories based on Type: chemotherapy, radiation therapy, steroid therapy, targeted therapy, and others. The chemotherapy segment dominates the market. Chemotherapy is a primary treatment for CNS lymphoma. High-dose methotrexate is commonly used because it can cross the blood-brain barrier and target cancer cells within the central nervous system.

The market is divided into three categories based on Application: therapeutics, clinical trials, and others. The therapeutics segment is projected to hold the largest share of the market. Amnestic Therapeutics treatment is highly preferred in CNS treatment which boosts segment growth.

The market is divided into three categories based on End Users: hospitals, clinics, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. Advances in diagnostic technologies, such as MRI, PET scans, and cerebrospinal fluid analysis, have improved hospitals' treatment facilities.

Central Nervous System Lymphoma Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a significant share of the CNS lymphoma treatment market due to high incidence rates, advanced healthcare infrastructure, and substantial research investments. The U.S. leads in clinical trials and the development of new therapies, including targeted therapies and immunotherapies. The FDA's approval processes, including fast-tracking promising treatments, support market growth.

Central Nervous System Lymphoma Treatment Market- Competitive Landscape:

The Central Nervous System Lymphoma Treatment market is moderately competitive. Major pharmaceutical and biotech companies, such as Roche, Bristol-Myers Squibb, Novartis, Eli Lilly, and Celgene, are active in CNS lymphoma treatment development. Companies are getting the FDA approval for several new therapies targeting CNS lymphoma, including innovative treatments such as monoclonal antibodies and novel chemotherapeutic agents. Leading companies include players such as Bayer, Sanofi, AstraZeneca, and GSK have a significant presence across globe.

Recent Developments:

In 2023, Kite Pharma and Bristol-Myers Squibb collaborated to develop CAR T-cell therapies, which show promise in treating various types of lymphomas, including CNS lymphoma.

In 2023, Novartis AG introduced a drug called Pembrolizumab for treating intraocular melanoma cancer type disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CENTRAL NERVOUS SYSTEM LYMPHOMA TREATMENT MARKET KEY PLAYERS

  • Roche
  • Bristol-Myers Squibb
  • Novartis AG
  • Eli Lilly
  • Celgene
  • Kite Pharma
  • Merck & Co.
  • AstraZeneca
  • Sanofi
  • AbbVie
  • Takeda Pharmaceuticals
  • Pfizer
  • Beigene
  • Eisai
  • Johnson & Johnson
  • Others

GLOBAL CENTRAL NERVOUS SYSTEM LYMPHOMA TREATMENT MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Chemotherapy
  • Radiation therapy
  • Steroid therapy
  • Targeted therapy
  • Others

GLOBAL CENTRAL NERVOUS SYSTEM LYMPHOMA TREATMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Therapeutics
  • Clinical trials
  • Others

GLOBAL CENTRAL NERVOUS SYSTEM LYMPHOMA TREATMENT MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinics
  • Others

GLOBAL CENTRAL NERVOUS SYSTEM LYMPHOMA TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Central Nervous System Lymphoma Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Central Nervous System Lymphoma Treatment Market Snippet by Type
    • 2.1.2. Central Nervous System Lymphoma Treatment Market Snippet by Application
    • 2.1.3. Central Nervous System Lymphoma Treatment Market Snippet by End User
    • 2.1.4. Central Nervous System Lymphoma Treatment Market Snippet by Country
    • 2.1.5. Central Nervous System Lymphoma Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Central Nervous System Lymphoma Treatment Key Market Trends

  • 3.1. Central Nervous System Lymphoma Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Central Nervous System Lymphoma Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Central Nervous System Lymphoma Treatment Market Opportunities
  • 3.4. Central Nervous System Lymphoma Treatment Market Future Trends

4. Central Nervous System Lymphoma Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Central Nervous System Lymphoma Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Central Nervous System Lymphoma Treatment Market Landscape

  • 6.1. Central Nervous System Lymphoma Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Central Nervous System Lymphoma Treatment Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Chemotherapy
    • 7.1.3. Radiation therapy
    • 7.1.4. Steroid therapy
    • 7.1.5. Targeted therapy
    • 7.1.6. Others

8. Central Nervous System Lymphoma Treatment Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Therapeutics
    • 8.1.3. Clinical trials
    • 8.1.4. Others

9. Central Nervous System Lymphoma Treatment Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others
    • 9.1.5. Pharmacy

10. Central Nervous System Lymphoma Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Central Nervous System Lymphoma Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Central Nervous System Lymphoma Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Central Nervous System Lymphoma Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Central Nervous System Lymphoma Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Central Nervous System Lymphoma Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Central Nervous System Lymphoma Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Roche
    • 11.2.2. Bristol-Myers Squibb
    • 11.2.3. Novartis AG
    • 11.2.4. Eli Lilly
    • 11.2.5. Celgene
    • 11.2.6. Kite Pharma
    • 11.2.7. Merck & Co.
    • 11.2.8. AstraZeneca
    • 11.2.9. Sanofi
    • 11.2.10. AbbVie
    • 11.2.11. Takeda Pharmaceuticals
    • 11.2.12. Pfizer
    • 11.2.13. Beigene
    • 11.2.14. Eisai
    • 11.2.15. Johnson & Johnson
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us